Guenter Janhofer - Oct 23, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Signature
/s/ Brendan Hannah, Attorney-in-Fact for Guenter Janhofer, M.D., Ph.D.
Stock symbol
QNCX
Transactions as of
Oct 23, 2023
Transactions value $
$0
Form type
4
Date filed
10/24/2023, 07:42 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent of the shares subject to the stock option vests on the first anniversary of the grant date of October 23, 2023, and the remainder vests in 36 equal monthly installments thereafter for the following three years, subject to the Reporting Person's continuous service as the officer of the Issuer as of each such date.